ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Helsinn Healthcare SA clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 42 studies whose lead sponsor is Helsinn Healthcare SA or the company grouped under it. 1 is recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 6, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Helsinn Healthcare with Bristol-Myers Squibb and Vanda Pharmaceuticals →

Pipeline: 2 programs

Each counted once: 2 with a study Helsinn Healthcare SA leads registered in the last two years.

  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Helsinn Healthcare SA’s own registered studies; Helsinn Healthcare SA’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Helsinn Healthcare SA’s studies test, most studies first; none is open now — 9 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

1 of Helsinn Healthcare SA’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. 1O
  13. N

Add it to your calendar (.ics) → With an account.

All 42 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now12%
  • Completed3379%
  • Stopped early819%Terminated 6 · Withdrawn 2

Phase

  • Phase 316
  • Phase 215
  • Phase 14
  • Phase 41
  • Early Phase 11

Where

  • United States29
  • Hungary14
  • Poland14
  • Russian Federation13
  • Germany12
  • Ukraine12

Over the years

  1. 08
  2. 09
  3. 10
  4. 911
  5. 12
  6. 13
  7. 14
  8. 15
  9. 16
  10. 17
  11. 18
  12. 19
  13. 20
  14. 21
  15. 22
  16. 23
  17. 24
  18. 25
  19. 026

By the year each study started; 4 started before 2008. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Helsinn Healthcare SA.

  • Helsinn Healthcare SA
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    32 studies
  • Helsinn Therapeutics (U.S.), Inc
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →

Focus areas

Conditions Helsinn Healthcare SA leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 42 of 42.